These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 13504274)

  • 21. [Contribution to the diagnosis of myocardial infarct. Note 2. The determination of glutamic-oxalacetic transaminase and lactic dehydrogenase in acute myocardial infarct].
    FONNESU V; MARTINELLI M; SILVESTRI G
    Riforma Med; 1960 May; 74():543-8. PubMed ID: 13700583
    [No Abstract]   [Full Text] [Related]  

  • 22. Serum glutamic oxalacetic transaminase in acute myocardial infarction.
    DEWAR HA; ROWELL NR; SMITH AJ
    Br Med J; 1958 Nov; 2(5105):1121-5. PubMed ID: 13584872
    [No Abstract]   [Full Text] [Related]  

  • 23. [Serum glutamic oxaloacetic transaminase in myocardial infarct & liver diseases: general review].
    BELANGER M; LESSARD A
    Laval Med; 1958 Jun; 26(1):74-110. PubMed ID: 13564853
    [No Abstract]   [Full Text] [Related]  

  • 24. [Glutamic-oxalacetic transaminase and electrocardiographic changes in the course of the development of myocardial infarct].
    PERNOT C; de LAVERGNE ; RENAUD J; BROUANT B
    Rev Med Nancy; 1959 Oct; 84():970-82. PubMed ID: 14431926
    [No Abstract]   [Full Text] [Related]  

  • 25. Transaminase; importance of serial determinations of serum glutamic oxalacetic transaminase in differential diagnosis of myocardial infarction.
    FRIMPTER GW
    Northwest Med; 1959 Jun; 58(6):831-6. PubMed ID: 13667079
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum glucose-6-phosphate dehydrogenase in the diagnosis of myocardial infarction. Comparison of its clinical value with that of glutamic-oxalacetic transaminase.
    KERPPOLA W; NIKKILA EA; PITKANEN E
    Acta Med Scand; 1960 Jan; 166():17-24. PubMed ID: 14408628
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum glutamic oxalacetic transaminase activity in acute coronary thrombosis with myocardial infarction. Relation to prognosis.
    MCCALL M; HERTZ A; RAPPAPORT I; NELSON W
    Am J Cardiol; 1961 May; 7():673-5. PubMed ID: 13773744
    [No Abstract]   [Full Text] [Related]  

  • 28. [The elevation of the glutamic-oxalacetic transaminase level in the blood after myocardial infarction. Critical study and diagnostic value].
    WELTI JJ; NIVET M
    Presse Med (1893); 1960 Apr; 68():826-8. PubMed ID: 13843938
    [No Abstract]   [Full Text] [Related]  

  • 29. [Blood transaminases in cardiovascular pathology; value of the simultaneous determination of blood glutamic oxalacetic & glutamic pyruvic transaminases].
    BRUYET P; BENEVENT J; LYON D; ISORNI P; DELAUNAY A; MEIGNIEN C
    Arch Mal Coeur Vaiss; 1958 Aug; 51(8):758-71. PubMed ID: 13572135
    [No Abstract]   [Full Text] [Related]  

  • 30. Lactic dehydrogenase versus glutamic oxalacetic acid transaminase as a diagnostic test for myocardial infarction.
    FREEMAN I; JACKSON DA; COLLIER CS
    Am J Med Sci; 1959 Jun; 237(6):768-70. PubMed ID: 13661165
    [No Abstract]   [Full Text] [Related]  

  • 31. The serum glutamic oxalacetic transaminase determination: its clinical use in the diagnosis of myocardial infarction and in the differential diagnosis of chest pains.
    SELIGSON D; ZINGESSER LH; GOLDSTEIN F
    Pa Med J; 1957 Jun; 60(6):728-34. PubMed ID: 13431381
    [No Abstract]   [Full Text] [Related]  

  • 32. [Value of the determination of serum glutamic-oxalacetic transaminase and serum glutamic-pyruvic transaminase in the diagnosis of myocardial infarct and liver disease].
    BOSTANCI N; BIYAL F
    Turk Tip Cemiy Mecm; 1959 Sep; 25():444-54. PubMed ID: 13803091
    [No Abstract]   [Full Text] [Related]  

  • 33. [Transaminases. I. Biological study: significance of blood glutamic oxalacetic transaminases in cardiac pathology].
    PEREZ C; ZERAH A
    Tunis Med; 1958 Dec; 36(10):599 passim. PubMed ID: 13635876
    [No Abstract]   [Full Text] [Related]  

  • 34. Experiences with Frankel's & Reitman's blood glutamic-oxaletic-transaminase determination with special reference to myocardial infarct.
    GROEN A; SAUVEPLANNE AL; KOOPS G
    Ned Tijdschr Geneeskd; 1958 Aug; 102(34):1641-5. PubMed ID: 13590313
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum glutamic-oxalacetic transaminase activity in conditions associated with myocardial infarction. II. Cerebral vascular accidents and congestive heart failure.
    LIEBERMAN J; LASKY II; DULKIN SI; LOBSTEIN OE
    Ann Intern Med; 1957 Mar; 46(3):497-505. PubMed ID: 13403533
    [No Abstract]   [Full Text] [Related]  

  • 36. Glutamic oxalacetic transaminase and C-reactive protein in myocardial infarction, with special reference to the electrocardiographic pattern.
    BURSTEIN J; HARJANNE A
    Acta Med Scand; 1959 Mar; 163(3):175-84. PubMed ID: 13636816
    [No Abstract]   [Full Text] [Related]  

  • 37. [Serum transaminase activity in myocardial infarct].
    ILIESCU CC; ROMAN L; BANU I; SOIMU I; ORGHIDAN G
    Med Interna (Bucur); 1958 Jan; 10(1):77-84. PubMed ID: 13516089
    [No Abstract]   [Full Text] [Related]  

  • 38. [Glutamic-oxalacetic transaminases and lactic dehydrogenases in myocardial infarct].
    RULLI V; CONCINA B
    Cuore Circ; 1960 Jun; 44():156-68. PubMed ID: 14440168
    [No Abstract]   [Full Text] [Related]  

  • 39. [Determination of serum transaminase as diagnostic aid in myocardial infarct].
    DAL PRA L
    Ann Med Nav (Roma); 1957; 62(5):611-2. PubMed ID: 13498566
    [No Abstract]   [Full Text] [Related]  

  • 40. Differences in the distribution of glutamic acid-oxalacetic acid transaminase- and aldolase-activity among serum protein fractions in patients with acute myocardial infarct and hepatocellular damage.
    TENYI M; VARGA L; KOVACS I; LEHOTAY L
    Med Exp Int J Exp Med; 1961; 4():335-40. PubMed ID: 13920250
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.